News

Abbott in collaboration with IQVIA highlights that 44% of people have been living with vertigo for more than a year, experiencing episodes once a week. Many mistake vertigo for low blood sugar, low ...
Sterling Accuris strengthens presence in diagnostics through acquisition of Gujarat Pathology Laboratory and Diagnostic Centre: Our Bureau, Mumbai Thursday, April 17, 2025, 15:45 ...
LUMA Vision receives US FDA clearance for Verafeye 2D/4D cardiac visualization platform: Dublin Thursday, April 17, 2025, 16:00 Hrs [IST] LUMA Vision Ltd, an innovative leader in ...
ImmunityBio announces US FDA submissions of sBLA for NMIBC papillary disease and EAP for Anktiva to treat lymphopenia: Culver City, Calif Thursday, April 17, 2025, 15:00 Hrs [IST] ...
B. Braun introduces Ezcover Probe Cover Set for improved ultrasound safety in peripheral nerve block procedures: Bethlehem, Pennsylvania Thursday, April 17, 2025, 14:00 Hrs [IST] ...
Belhaven Biopharma announces promising study results from its dose confirmational clinical trial of Nasdepi: Raleigh, North Carolina Thursday, April 17, 2025, 13:00 Hrs [IST] Belh ...
Venus Remedies’ novel polymyxin B formulation, VRP-034 gets US FDA QIDP designation: Our Bureau, Bengaluru Thursday, April 17, 2025, 12:15 Hrs [IST] Venus Remedies’ investigat ...
QIAGEN to launch three new sample preparation instruments by 2026 to improve lab automation: Venlo, Netherlands Thursday, April 17, 2025, 11:00 Hrs [IST] QIAGEN, leading global pr ...
Study led by Karl Landsteiner University of Health Sciences reveals blind spots in India’s digital health landscape: Krems, Austria Thursday, April 17, 2025, 10:00 Hrs [IST] Sma ...
Open House in Dubai on April 24: Our Bureau, Bengaluru Thursday, April 17, 2025, 09:00 Hrs [IST] Authentication Solution ...
Exicure’s subsidiary, GPCR Therapeutics doses 19th patient in its phase 2 study of GPC-100 in multiple myeloma: Redwood City, California Wednesday, April 16, 2025, 18:00 Hrs [IS ...